A0712512
Alendronate sodium trihydrate , 97% , 121268-17-5
Synonym(s):
4-amino-1-hydroxy-1-phosphonobutyl phosphonic acid, monosodium;Alendronate sodium trihydrate;Alendronate, Sodium Salt - CAS 121268-17-5 - Calbiochem;Alendronate, Sodium, Trihydrate, 4-Amino-1-hydroxybutylidine-1,1-bisphosphonate;MK-217
CAS NO.:121268-17-5
Empirical Formula: C4H12NO7P2.Na.3H2O
Molecular Weight: 325.12
MDL number: MFCD01748233
EINECS: 601-766-4
Pack Size | Price | Stock | Quantity |
5G | RMB58.40 | In Stock |
|
25G | RMB141.60 | In Stock |
|
100G | RMB444.00 | In Stock |
|
500g | RMB1740.00 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 245°C |
storage temp. | -20°C |
solubility | water, double-distilled: 10 mg/mL |
form | solid |
color | white |
Water Solubility | Soluble in water at 10mg/ml |
Merck | 14,229 |
Stability: | Store in freezer |
InChIKey | NKENDYHBVCKCNL-UHFFFAOYSA-M |
Description and Uses
Alendronate sodium trihydrate is used as a bone resorption inhibitor, farnesyl diphosphate synthase inhibitor and CD45 protein tyrosine phosphatase inhibitor. A robust inhibitor of bone resorption that induces apoptosis. Alendronate inhibits the migration and invasion of PC-3 cells (sc-2220) by interfering with the mevalonate pathway. Additionally, Alendronate, Sodium Salt is an inhibitor of CD45RC and MMP.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P301+P312+P330 |
Hazard Codes | Xn,Xi |
Risk Statements | 22-36/37/38 |
Safety Statements | 26-36-60 |
WGK Germany | 3 |
RTECS | SZ6523500 |
HS Code | 29310095 |